Names & Terms You Will Hear
Plain-language meanings for the terms your care team may use.
| Term | Meaning |
|---|---|
| Stimulant medicine. | A medicine that raises certain brain chemicals. It helps with focus and attention. Adderall, Ritalin, Concerta, and Vyvanse are common brand names. |
| ADHD. | Short for attention-deficit/hyperactivity disorder. A stimulant is often the first medicine tried for it. |
| Amphetamine-based stimulants. | This group includes Adderall and Vyvanse. It also includes dextroamphetamine. |
| Methylphenidate-based stimulants. | This group includes Ritalin and Concerta. It works through a different brain pathway. The heart effect is similar. |
| Non-stimulant ADHD medicine. | A different type of ADHD drug. Atomoxetine, guanfacine, and viloxazine are examples. These are not stimulants. They still affect the heart. |
| Boxed warning. | The FDA's strongest label warning. On stimulant labels, it covers misuse and addiction. It is not about the heart. |
| Avoid-use warning. | A caution below a boxed warning. It calls for extra care. It does not mean the medicine is forbidden. |
| Raynaud phenomenon. | Fingers or toes that turn white or blue. They can feel numb or painful. Small blood vessels narrow too much. It is a known side effect for some people. |
What Is Stimulant Medications and Your Heart?
- Stimulant medicines raise two brain chemicals: dopamine and norepinephrine. This helps focus and impulse control in ADHD.
- These same chemicals also act on the body. They can raise heart rate and blood pressure a small amount. This is expected. It is not, by itself, a sign that something is wrong.
- Millions of children and adults take a prescribed stimulant every day. Most take it for years without a heart problem.
- This guide covers the common stimulants: Adderall, Vyvanse, dextroamphetamine, Ritalin, and Concerta. It also covers three non-stimulant options: atomoxetine, guanfacine, and viloxazine.
- The goal here is an honest middle ground. The heart effects are real. For most people at a normal dose, they are small and steady. This guide gives you the real numbers. It also gives you the exact signs that mean call us or call 911.
- If you already have a heart condition, see our High Blood Pressure guide. Talk with us before starting or changing any ADHD medicine.
Why It Matters
- In the largest pooled analysis, stimulants raised blood pressure by about 2 points on average. Heart rate rose by about 4 beats a minute. This came from 56 trials and over 10,000 people. It is high-certainty evidence.
- These changes do not fade with time. Trials of 8 weeks or longer showed the same small change. The effect stays steady. It does not keep growing.
- About 4 in 100 people stop a stimulant because of a side effect. This includes heart-related ones. Most people do not stop.
- In adults, resting heart rate rises by about 6 beats a minute on average. A resting rate above 90 shows up in about 4 in 100 people on a stimulant. That compares with about 2 in 100 not taking one.
- In children and teens, about 2 in 100 stop treatment for a heart-related effect.
- A small average change does not mean monitoring stops. See our Home Blood Pressure Monitoring guide to check your own numbers between visits.
What These Medicines Do to Blood Pressure and Heart Rate
- Stimulants raise two brain chemicals. These are dopamine and norepinephrine. The same chemicals act on blood vessels. They also act on the heart's pacemaker.
- The result is a small rise in blood pressure. Heart rate rises a little too. This is expected. It is not, by itself, a sign that something is wrong.
- The largest pooled trial data comes from 56 trials and over 10,000 people. The average change was about 2 points of systolic pressure. It was about 2 points of diastolic pressure. Heart rate rose about 4 beats a minute.
- This effect does not fade or grow over time. Trials of 8 weeks or longer showed the same small change.
- Your prescriber checks your blood pressure and heart rate at visits. See our Home Blood Pressure Monitoring guide to track your own numbers between visits.
Risk Factors
Knowing your personal risks helps your care team take extra precautions.
| Risk Factor | Why It Increases Risk |
|---|---|
| Years of continuous use. | Blood pressure risk grows with time on the medicine. It does not grow with any single dose. In one study of 278,027 people, the odds of high blood pressure rose about 1.7 times after 3 to 5 years. They rose about 1.8 times after more than 5 years. |
| Already having high blood pressure. | A stimulant adds a small amount on top. See our High Blood Pressure guide. |
| A structural heart problem. | One example is hypertrophic cardiomyopathy. The heart muscle may not handle the extra workload as easily. See our Hypertrophic Cardiomyopathy guide. |
| A serious heart rhythm problem. | This includes a rhythm problem present since birth. One study found the arrhythmia signal was highest in children with a congenital heart problem. See our Atrial Fibrillation guide and SVT guide. |
| A close relative who died suddenly and young. | Mention this to your prescriber, even without other symptoms. See our Anomalous Coronary Arteries guide for one inherited cause. |
| Getting older while on treatment. | The relative risk does not clearly change with age. But the real-world impact does. One estimate is about 0.19 extra events per 1,000 person-years at ages 25 to 44. It is about 0.77 at ages 45 to 64. |
| Taking an MAOI medicine. | This is a true, absolute contraindication. Combining it with a stimulant can spike blood pressure dangerously. Tell every prescriber about every medicine you take. |
Who Needs Extra Care Before Starting
- The only true contraindications on current labels are a known allergic reaction. The other is MAOI use within the last two weeks.
- A structural heart problem is now an avoid-use warning, not an automatic no. So is a serious rhythm history or coronary artery disease. See our Hypertrophic Cardiomyopathy guide. Talk with a heart doctor first.
- Before starting, your prescriber takes a targeted heart history. This includes your family's history too. Your prescriber also does a heart exam. Routine ECG testing is not recommended for most people.
- The American Heart Association and the American Academy of Pediatrics disagreed on ECG testing in 2008. Both later agreed an ECG is not mandatory. This history explains why advice can sound different.
- If a close relative died suddenly and young, mention it. See our Syncope Workup guide if you have had unexplained fainting.
Treatment Options
Shown in English for your safety — this section is not automatically translated. Confirm with your doctor or call the office.
- The FDA boxed warning on stimulant labels covers misuse and addiction. It is not about the heart. Older versions of this warning are sometimes still quoted.
- The only true contraindications on current labels are a known allergic reaction. The other is MAOI use within the last two weeks.
- A serious heart condition is now labeled an avoid-use warning. This includes a structural heart problem or a major arrhythmia. Talk with a heart doctor first. It is not an automatic no.
- Before starting, your prescriber asks about your heart history. This includes your family's history too. Your prescriber also does a heart exam. Routine ECG testing before starting is not recommended by current guidance.
- Two major medical groups disagreed on ECG testing back in 2008. These were the American Heart Association and the American Academy of Pediatrics. Both later agreed an ECG is not mandatory. That history is why advice can sound conflicting.
- At follow-up visits, your prescriber checks your blood pressure and heart rate. See our Ambulatory Blood Pressure Monitor guide if longer monitoring is ever needed.
- How often to check in is a talk for you and your own physician. What counts as a change worth acting on is too. There is no single fixed schedule for everyone.
- If an ECG is done for another reason, see our Abnormal EKG guide for what a finding might mean.
Who Needs Extra Care Before Starting
| Situation | What it means for you |
|---|---|
| A known allergic reaction to this type of medicine. | A true contraindication. This medicine should not be used. |
| Taking an MAOI medicine, or stopped one within the last 2 weeks. | A true contraindication. Combining them can cause a dangerous blood pressure spike. |
| A structural heart problem. One example is hypertrophic cardiomyopathy. Another is a heart valve problem present since birth. | An avoid-use warning. Talk with a heart doctor before starting. |
| A serious heart rhythm problem in your history. | An avoid-use warning. Talk with a heart doctor before starting. |
| Coronary artery disease or a past heart attack. | An avoid-use warning. Talk with a heart doctor before starting. |
| Blood pressure that is not yet well controlled. | Not an absolute bar. Get your blood pressure under control first, if possible. |
| A close relative who died suddenly and young. | Worth mentioning to your prescriber, even without other symptoms. |
If You Also Have Heart Disease: Alternatives and Trade-offs
- Non-stimulant medicines are not automatically gentler on the heart. Atomoxetine raised heart rate more than the stimulants did. This was the largest effect of any ADHD drug studied head-to-head.
- Guanfacine works differently. It lowers blood pressure and heart rate instead of raising them. This can help in certain heart conditions. It has its own side effects to discuss with your prescriber.
- Viloxazine is a newer non-stimulant option. Ask your prescriber about its specific effect on the heart.
- For anyone with known heart disease, the choice is usually made together. Your cardiologist and your ADHD prescriber weigh symptom control against your heart condition. This is sometimes called a Heart Team approach.
- Whichever medicine you use, the same rule applies. Never stop or switch on your own. Call us first. See our Stress and Mental Health guide if untreated ADHD symptoms affect your stress in the meantime.
Never stop a prescribed stimulant on your own. Call us first, unless you have a 911 symptom. Stopping suddenly does not protect your heart. It only brings back your ADHD symptoms. If you notice a change, call us. We can check it. We can adjust the dose or switch medicines, often without any gap in treatment.
Comfort Measures at Home (No Medication Needed)
These simple steps support healing and ease symptoms. Use them alongside any medication your doctor prescribes.
- Learn your own resting heart rate and blood pressure before starting. See our Home Blood Pressure Monitoring guide.
- Take the medicine exactly as prescribed. Taking more than prescribed raises heart effects without adding benefit.
- Ask before combining with other stimulating substances. This includes a lot of caffeine. It also includes some decongestants and diet supplements.
- Keep up other heart-healthy habits. Stay active, sleep well, and manage stress. See our Exercise and Your Heart guide and Stress and Mental Health guide.
- Alcohol and stimulants both affect the heart. If you drink, know how the two interact. See our Alcohol and Heart Health guide.
- Tell every doctor, dentist, and pharmacist that you take a stimulant. This matters most before surgery.
- Carry a simple list of your medicines. Include the exact stimulant and dose.
- If you notice a new racing or skipped heartbeat, mention it at your next visit. See our Palpitations Workup guide.
- If your fingers or toes turn pale, blue, or numb in the cold, mention it too. This can improve with a lower dose.
Risks, Benefits, and Alternatives
Shown in English for your safety — this section is not automatically translated. Confirm with your doctor or call the office.
Every choice has trade-offs. Use this table to start the shared decision conversation with your care team.
| Option | Risks | Benefits | Alternatives |
|---|---|---|---|
| Continuing your prescribed stimulant as directed. | A small, steady rise in blood pressure and heart rate for most people. This signal grows with years of continuous use. | Effective symptom control for ADHD. The serious-event rate does not rise above that of non-users in the largest studies. | A dose change. A different stimulant. Or a non-stimulant medicine, discussed with your prescriber. |
| Switching to a non-stimulant medicine. | Not automatically gentler on the heart. Atomoxetine raised heart rate more than the stimulants did in one study. | Guanfacine lowers blood pressure and heart rate instead. This can help in certain heart conditions. | Staying on a stimulant with closer monitoring, if it is working well. |
| Stopping the medicine on your own. | Loss of symptom control. No proven heart benefit from stopping abruptly. This is never the first step to take. | None. There is no evidence this protects the heart at a normal, prescribed dose. | Call us instead. We can adjust the dose or switch medicines. Often this happens without any treatment gap. |
| Getting a routine ECG before starting. | Not part of current guidance for most patients. It can create confusion if a normal variant looks like a problem. | A targeted history and physical exam catch the concerns that matter most. | An ECG or echocardiogram if your history raises a specific concern. |
Common Misconceptions
| Myth | Reality |
|---|---|
| The boxed warning on my stimulant label is about my heart. | It is not. The FDA boxed warning on current labels covers misuse and addiction. It is not a heart warning. |
| I cannot take this medicine if I have any heart condition. | Not true for most heart conditions. The only true contraindications are a known allergic reaction and MAOI use. Serious heart disease is now an avoid-use warning, not an automatic no. |
| I need an ECG before I can start. | Current guidance does not recommend a routine ECG for most people. A targeted history and heart exam matter more. See our Abnormal EKG guide if one is done for another reason. |
| Stimulants carry a QT-interval warning. | They do not. That caution is on the label of atomoxetine, a non-stimulant medicine. It is not on stimulant labels. See our Long QT guide for what QT means. |
| If my heart rate rises a little, I should stop the medicine myself. | Call us first, unless you have a 911 symptom. A small, steady rise is expected. It usually does not mean stopping. |
| A non-stimulant option is automatically safer for my heart. | Not always. Atomoxetine raised heart rate more than the stimulants did in one study. Guanfacine is the one that lowers it instead. |
| A prescribed stimulant is the same as street drug misuse. | It is not. Heart damage from methamphetamine is a known result of drug misuse. It happens at doses nothing like a prescribed pill. It is not an established effect of proper ADHD treatment. |
Possible Complications
Knowing what can go wrong helps you spot problems early. Most complications are uncommon, especially with treatment.
| Where / What | What Can Happen |
|---|---|
| Heart, blood pressure. | A small average rise: about 2 points systolic, about 2 points diastolic. With years of use, the odds of high blood pressure rise too. That is about 1.7 times at 3 to 5 years, about 1.8 times beyond 5 years. See our High Blood Pressure guide. |
| Heart, rate and rhythm. | Resting heart rate rises by about 4 to 6 beats a minute on average. One large study found an arrhythmia signal too. It was highest in children who already had a congenital heart problem. See our Atrial Fibrillation guide, SVT guide, and Holter Monitor guide. |
| Heart, exertional chest discomfort. | Chest pain during exertion is not an expected side effect. It always deserves prompt evaluation. See our Chest Pain guide. |
| Circulation, hands and feet. | Fingers or toes can turn white or blue. They can feel numb or painful. This is called Raynaud phenomenon. It is a named label warning. It usually improves with a lower dose. |
| Heart, rare serious events. | In children and young adults, serious events happen at about 3 per 100,000 person-years. There was no increase in users versus non-users, across 1.2 million young people. In adults, no increased risk was found versus past users. The absolute extra risk still rises somewhat with age. |
| Heart, sudden death in children. | 19 deaths occurred among 2.5 million children on stimulants over 5 years. That is fewer than 2 per million children per year. It is lower than the background rate in children not on any stimulant, which runs about 8 to 62 per million. |
What the Large Studies Actually Found
- One study followed 1.2 million children and young adults, for 2.6 million person-years. Serious events happened at about 3 per 100,000 person-years. There was no increase in stimulant users versus non-users.
- A separate report found 19 sudden deaths. These were among 2.5 million children on stimulants over 5 years. That is fewer than 2 per million children a year. It is lower than the background rate, which runs about 8 to 62 per million.
- In adults, one study of 150,359 users found no increased risk versus past users. The absolute extra risk still rises somewhat with age. It is about 0.19 extra events per 1,000 person-years at ages 25 to 44. It is about 0.77 at ages 45 to 64.
- The clearest real signal is high blood pressure. It builds with years of continuous use, not a single dose. In a study of 278,027 people, the odds were about 1.7 times higher at 3 to 5 years. They were about 1.8 times higher beyond 5 years.
- A separate arrhythmia signal used a different design. Each person served as their own control. The signal was highest in children who already had a congenital heart problem.
- Studies do not agree on every question. One large analysis found a pooled signal for sudden death and arrhythmia. That signal lost its significance when only the strongest study designs were counted. We are telling you about that disagreement, not picking a side for you.
Points to Know
Shown in English for your safety — this section is not automatically translated. Confirm with your doctor or call the office.
If you remember nothing else, remember these key points.
- The average heart effect of a prescribed stimulant is small: about 2 points of blood pressure, about 4 beats a minute of heart rate.
- These small changes are steady over time. They do not build up the longer you take the medicine.
- The heart-related boxed warning you may have heard about does not exist on current stimulant labels. The boxed warning covers misuse and addiction.
- Most heart conditions are now labeled avoid-use, not an absolute bar. Talk with your cardiologist and prescriber together.
- The strongest real signal is high blood pressure that builds with years of use, not a single dose. This is why ongoing checks matter.
- Sudden death in children on stimulants is lower than the background rate, not higher.
- Never stop a prescribed stimulant on your own. Call us first, unless you have a 911 symptom.
- Know the specific signs that mean call us versus call 911. They are listed below.
When to Call Us — and When to Call 911
Shown in English for your safety — this section is not automatically translated. Confirm with your doctor or call the office.
If you are not sure, call. We would rather hear from you twice than miss a real problem.
- Call 911 for chest pain or pressure, especially with exertion, sweating, or shortness of breath.
- Call 911 for sudden fainting, or a racing or pounding heartbeat that does not stop and comes with dizziness.
- Call 911 for sudden weakness, slurred speech, or a drooping face. These are stroke signs.
- Call us this week for a resting heart rate or blood pressure that feels persistently higher than usual for you.
- Call us this week for fingers or toes that turn pale, blue, or numb and painful.
- Call us before you stop or change the dose on your own. We would rather hear from you first.
- Call us if a close relative died suddenly and unexpectedly at a young age, even if you feel fine.
Office: (727) 943-5200
What to Do: Mention It, Call Us, or Call 911
| What you notice | What to do |
|---|---|
| Mild jitteriness or restlessness that fades in a few hours. A dry mouth. Reduced appetite. Trouble falling asleep if the dose is taken late in the day. | Mention it at your next regular visit. |
| A resting heart rate or blood pressure that feels persistently higher than usual for you. New or worsening headaches. Fingers or toes turning pale, blue, or numb and painful. | Call us before your next dose. Do not just wait. |
| Chest pain or pressure, especially with exertion. Fainting or sudden loss of consciousness. A racing or pounding heartbeat that will not stop, with dizziness or shortness of breath. Sudden weakness, slurred speech, or facial drooping. | Call 911 now. |
Red flags that mean call 911 now: chest pain or pressure with exertion. Fainting or sudden loss of consciousness. A racing or pounding heartbeat that will not stop, with dizziness or shortness of breath. Sudden weakness, slurred speech, or facial drooping. Do not wait these out. See our Cardiac Arrest guide for what happens after that call.
Trusted Resources
Independent, evidence-based pages we recommend for deeper reading.
- Cleveland Clinic - ADHD Medications and Your Heart — Plain-language overview of how ADHD medicines are used and monitored for heart safety.
- American Heart Association - Understanding Blood Pressure Readings — How to read your blood pressure numbers and what the categories mean.
- FDA / DailyMed - Adderall Prescribing Information — The current official label, including the boxed warning, contraindications, and avoid-use warnings described in this guide.
Sources Used to Build This Guide
- Ostinelli EG, et al. Amphetamines for Attention Deficit Hyperactivity Disorder in Adults. Cochrane Database Syst Rev. 2025. [meta-analysis] — High-certainty pooled hemodynamic effect across 56 trials and 10,583 participants: systolic pressure up about 1.9 mmHg, diastolic up about 1.8, heart rate up about 3.7 beats per minute. Also the finding that these effects were sustained in trials of 8 weeks or longer rather than fading.
- Mick E, et al. Meta-analysis of Increased Heart Rate and Blood Pressure Associated with CNS Stimulant Treatment of ADHD in Adults. Eur Neuropsychopharmacol. 2013;23(6):534-41. [meta-analysis] — Adult-specific figures: resting heart rate up 5.7 beats per minute, and a resting rate above 90 in 4.2% on stimulant versus 1.7% on placebo. The best available answer to how often something clinically meaningful shows up.
- Hennissen L, et al. Cardiovascular Effects of Stimulant and Non-stimulant Medication for Children and Adolescents with ADHD: Systematic Review and Meta-analysis. CNS Drugs. 2017;31(3):199-215. [meta-analysis] — Children and adolescents across 18 trials: about 2% stopped treatment for a cardiovascular effect. Also the head-to-head showing atomoxetine raised heart rate more than the stimulants did.
- Cooper WO, et al. ADHD Drugs and Serious Cardiovascular Events in Children and Young Adults. N Engl J Med. 2011;365(20):1896-904. [cohort] — 1.2 million young people, 2.6 million person-years: 3.1 serious cardiovascular events per 100,000 person-years, with no increase in users (hazard ratio 0.75). The central reassurance figure for children and young adults.
- Habel LA, et al. ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults. JAMA. 2011;306(24):2673-83. [cohort] — 150,359 adult users, 806,182 person-years, no increased risk versus remote use. Also the age gradient in absolute terms: the same upper risk bound means about 0.19 extra events per 1,000 person-years at ages 25 to 44 but 0.77 at ages 45 to 64.
- Zhang L, et al. Attention-Deficit/Hyperactivity Disorder Medications and Long-Term Risk of Cardiovascular Diseases. JAMA Psychiatry. 2024;81(2):178-187. [case-control] — 278,027 people followed up to 14 years. Risk rose with cumulative use, and high blood pressure was the strongest signal: odds ratio 1.72 at three to five years and 1.80 beyond five years. The reason blood-pressure monitoring does not stop after the dose is settled.
- Shin JY, et al. Cardiovascular Safety of Methylphenidate Among Children and Young People with ADHD: Nationwide Self-controlled Case Series Study. BMJ. 2016;353:i2550. [cohort] — The clearest arrhythmia signal: incidence rate ratio 1.61, and highest in children who had congenital heart disease. Each patient serves as their own control, so fixed differences between people cannot explain it.
- Liu H, et al. Cardiovascular Safety of Stimulants in Children and Adolescents with ADHD: Meta-analysis. Eur Child Adolesc Psychiatry. 2019;28(10):1283-1293. [meta-analysis] — 4.2 million participants. Pooled sudden death and arrhythmia risk ratio 1.39, but this loses significance when only cohort studies are pooled (1.24). Used to represent the disagreement honestly rather than pick a side.
- Zhang L, et al. Risk of Cardiovascular Diseases Associated with Medications Used in ADHD: Systematic Review and Meta-analysis. JAMA Netw Open. 2022;5(11):e2243597. [meta-analysis] — 19 studies, 3.9 million participants, with risk estimates broken out by age group. No result reached significance, but the estimates rise with age, which supports treating older starters more carefully.
- Westover AN, Halm EA. Do Prescription Stimulants Increase the Risk of Adverse Cardiovascular Events? Systematic Review. BMC Cardiovasc Disord. 2012;12:41. [systematic-review] — The structural finding that six of seven pediatric studies were reassuring while two of three adult studies were not. The basis for treating children and adults as different questions.
- Perrin JM, Friedman RA, Knilans TK, et al. Cardiovascular Monitoring and Stimulant Drugs for Attention-Deficit/Hyperactivity Disorder (AAP Policy Statement). Pediatrics. 2008;122(2):451-453. [guideline] — The sudden-death anchor: 19 deaths among 2.5 million children on stimulants over five years, fewer than 2 per million per year, against a background rate of 8 to 62 per million. Also the recommendation for targeted history and cardiac exam rather than routine ECG.
- Vetter VL, et al. Cardiovascular Monitoring of Children and Adolescents with Heart Disease Receiving Medications for ADHD (AHA Scientific Statement). Circulation. 2008;117(18):2407-2423. [guideline] — The American Heart Association position that an ECG before starting is reasonable, which the American Academy of Pediatrics publicly disputed. Both bodies later clarified that an ECG is not mandatory. Used to explain why patients hear conflicting advice.
- US Food and Drug Administration. Adderall (dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, amphetamine sulfate) Prescribing Information. DailyMed. [label] — Current official labeling: the boxed warning covers abuse and addiction, not the heart; the only contraindications are hypersensitivity and MAOI use; serious cardiac disease appears as an avoid-use warning; and peripheral vasculopathy including Raynaud phenomenon is a named warning.
- US Food and Drug Administration. Concerta (methylphenidate HCl extended-release) Prescribing Information. DailyMed. [label] — Methylphenidate labeling, including the instruction to monitor all treated patients for high blood pressure and fast heart rate, and the warning that stimulants may reduce the effectiveness of blood-pressure medicines.
- US Food and Drug Administration. Vyvanse (lisdexamfetamine dimesylate) Prescribing Information. DailyMed. [label] — Third current stimulant label, confirming that the cardiovascular language is a class-wide pattern rather than specific to one product.
- Liang EF, et al. The Effect of Methylphenidate and Atomoxetine on Heart Rate and Systolic Blood Pressure in Young People and Adults with ADHD: Systematic Review and Meta-analysis. Int J Environ Res Public Health. 2018;15(8):1789. [meta-analysis] — 46,107 participants. Found dose to be a significant moderator of blood-pressure and heart-rate effects, and found atomoxetine raised heart rate and systolic pressure more than methylphenidate did.
- Torres-Acosta N, O'Keefe JH, O'Keefe CL, Lavie CJ. Cardiovascular Effects of ADHD Therapies. J Am Coll Cardiol. 2020;76(7):858-866. [review] — Cardiology-facing synthesis of stimulant and non-stimulant cardiovascular effects, and the assessment that reported cardiomyopathy cases do not establish causation.
- Somma V, et al. Methamphetamine-associated Cardiomyopathy. Intern Med J. 2023;53(4):481-488. [review] — The far end of the spectrum: methamphetamine-associated heart failure is the second leading cause of death in people with methamphetamine use disorder, and treatment depends on stopping the drug. Used to draw the line between prescribed dosing and misuse honestly.
- Schelleman H, et al. Cardiovascular Events and Death in Children and Adults Exposed to ADHD Medications. PLoS One. 2013;8(3):e52991. [cohort] — Adult users of amphetamines and atomoxetine with no significant increase in sudden death, stroke, or heart attack, while noting the confidence intervals do not exclude modest increases.
- Winterstein AG, et al. Cardiovascular Safety of Central Nervous System Stimulants in Children and Adolescents. Pediatrics. 2011;127(6):1102-10. [cohort] — 241,417 children starting stimulants, with no validated heart attacks or strokes identified among medication users.
- Cleveland Clinic. ADHD Medications and Your Heart. [patient-education] — Plain-language framing and patient-facing context for how these medicines are used and monitored.
- American Heart Association. High Blood Pressure — Understanding Blood Pressure Readings. [patient-education] — Reference for home blood-pressure numbers and what the categories mean, supporting the monitoring section.
